Contrast Media Injectors Market
Market Insights on Contrast Media Injectors covering sales outlook, demand forecast & up-to-date key trends
Contrast Media Injectors Market by Product (CT Injectors, MRI Injectors, and Cardio Injectors), by End User (Hospitals, Ambulatory Surgical Centres, and Diagnostics Centres) & Region - Forecast 2022-2030
Contrast Media Injectors Market Snapshot
[269 pages Report] The global contrast media injectors market was valued at US$ 1.4 Bn in 2021 and is expected to reach US$ 2.4 Bn by 2030, finds Future Market Insights (FMI) in a recent market survey.
|
Data Points |
Market Insights |
|
Market Value 2021 |
USD 1.4 Bn |
|
Market Value 2022 |
USD 1.5 Bn |
|
Market Value 2030 |
USD 2.4 Bn |
|
CAGR 2022-2030 |
6.2% |
|
Key Players |
The key players are Bayer AG, Nemoto Kyorindo Co. Ltd., Mallinckrodt, Bracco Imaging, Ulrich GmBh, Guerbet SA, Medtron AG, |
|
Share of Top 5 Countries |
58.1% |
Growing prevalence of trauma cases, rising number of radiology procedures using contrast media, increase in geriatric population and growth of diagnostic imaging centers are primary factors boosting growth of the contrast media injectors market.
Moreover, use of contrast media in radiology to enhance image quality for diagnosis of tumor is projected to develop significantly in the estimate period owing to increasing prevalence of cancer worldwide. All these factors are expected to drive the market growth further.
Contrast media injectors market holds nearly 4.2% market value share of the US$ 36.1 Bn diagnostic imaging market in 2021. In addition, increasing awareness among physicians regarding patient safety during contrast media insertion is forcing market players to upgrade safety parameters in contrast media injectors.
Strengthening of supply chain, particularly in regions such as Asia Pacific and Middle East and Africa, are the key focus areas for players in this market. There is an increasing necessity to efficiently meet needs of various healthcare facilities, while ensuring supply of the best contrast media products, as quality is of utmost importance to end users.
Governments are providing ample funding for diagnostic imaging services, with funding increasing substantially each year owing to increasing applications of diagnostic imaging in the field of radiology and image-guided minimally invasive surgery.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1 – 2021 |
5.86% |
|
H1 – 2022 Projected |
6.22% |
|
H1 – 2022 Outlook |
6.12% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change– H1, 2022 (O) – H1, 2021 |
(+) 26 ↑ |
The variation between the BPS values observed within this market in H1, 2022 - Outlook over H1, 2022 Projected reflects a decline of 10 BPS units. According to an FMI analysis, the market for contrast media injectors would grow by 26 basis share points (BPS) in H1-2022(O) as compared to H1-2021.
The rising BPS value for the contrast media injectors market can be ascribed to the growing demand for minimally invasive procedures, as well as the significant increase in financing and grants necessary to improve existing product lines.
The global contrast media injectors market is influenced by quality and safety regulations and licensure. Macroeconomic, regulatory, and industrial variables, all have an impact on the market.
The Imaging Bulk Package (IBP), a multi-patient, multi-dose compliant contrast medium approved by the FDA for POC usage in the CT suite was created to improve safety and workflow while reducing risk and preserving compliance with multi-dose CT contrast media, and is a key market development factor.
Other market segments, on the other hand, are expected to perform objectively and achieve lucrative growth prospects in the second half of the forecast period, especially with the development of CT and MRI contrasting agents.
2014-2021 Contrast Media Injectors Market Demand Outlook Compared to 2022-2030 forecast
Sales of contrast media injectors grew at a CAGR of 5.4% between 2014 and 2021.
The primary factors boosting the contrast media injector’s market growth are rising number of radiology procedures using contrast media and focus on reducing human error and increasing patient safety.
Contrast media is used to improve the diagnostic value to get imaging clearance. It helps distinguish selected areas of the body from surrounding tissue. It is for ease of physicians to diagnose disease by improving the visibility. So, healthcare professionals make it compulsory to undergo radiological testing with contrast media to come on any closing statement for particular disease.
Most of the hospitals and ambulatory surgical centers do the radiological procedures using contrast media for patients with chronic disease, accident, autoimmune diseases. All these patients mostly prefer to go to hospitals for testing in order to get proper diagnosis of disease. So this radiology procedures with contrast media give boost to the market.
Currently few contrast media injectors are available in the market that can be connected to the hospital’s IT system through which the system can directly access data from the hospital information systems (HIS) or electronic medical record (EMR) systems to adjust the dose, thus reducing human error. This creates opportunities for leading players to come up with innovative idea and bloom the market.
Considering this, FMI expects the global contrast media injectors market to grow at a CAGR of 6.2% through 2030.
Which Factors Are Restraining Demand for Contrast Media Injectors ?
Air emboli formation, which arises from a major air infusion that generates an air lock in the pulmonary artery, causes blood pressure to drop quickly, followed by cardiovascular collapse, is a major problem encountered during contrast media injection.
Air emboli formed during contrast media injection can restrict right ventricular outflow or clog pulmonary arterioles, resulting in significant complications such as cardiovascular collapse. The worldwide revenue growth of the contrast media injectors market is projected to be hampered by adverse consequences associated with contrast media injection.
End-user demand for technologically improved contrast media injectors, such as IT-enabled contrast media injectors that can connect to a hospital database for dosage monitoring, is driving up contrast media injector prices.
The rising cost of contrast media injectors is likely to restrict market growth throughout the forecast period, as most small and medium-sized hospitals are unable to purchase them. The demand from end users for creative advancements in contrast media injectors has resulted in a significant increase in the price of CT and MRI injectors, which is limiting the sale of these products to facilities without ample funding.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat is the Impact of the COVID-19 Crisis on the Contrast Media Injectors Market?
The COVID-19 epidemic had a terrible worldwide impact on population health as well as a significant economic impact on the majority of countries. The pandemic has put enormous strain on the world's healthcare systems. To prevent the spread of illness and save health care resources for COVID-19 patients, health care institutions and providers had been told to halt performing elective surgical operations and medical evaluations during this time.
The amount of imaging cases in many radiology departments has dropped dramatically. However, in very severe cases of COVID-19, contrast CT was utilized to diagnose COVID-19-related pneumonia. This resulted in a significant rise in adoption during COVID-19.
Nonetheless, there is expected to be a major increase in public knowledge of preventative medicines, but the future appears to be uncertain.
The demand for contrast media injectors will be largely determined by the amount of diagnostic imaging and the number of CT and MRI machines installed. We should expect diagnostic imaging demand to return to baseline in a few months, which might lead to a rebound in contrast injector demand.
The Covid-19 had a significant influence on the contrast media injector market in 2020, with sales dropping by roughly 20%. By 2022, the market is expected to return to its previous highs.
Country-wise Insights
What Makes the U.S. a Large Market for Contrast media injectors?
The U.S. is estimated to account for around 89.5% of the North America contrast media injectors market in 2022.
U.S. dominates the contrast media injectors market owing to favorable reimbursement policies, increase ageing population, rise in the regulatory approval of an increasing number of contrast agents and increasing government funding. The healthcare business in the U.S. is one of the well-known markets, in terms of product accessibility and innovations.
Additionally, increasing incidences of trauma cases globally is expected to fuel revenue growth of the contrast media injectors market over the forecast period in the region.
According to the American Association for the Surgery of Trauma reported data, in 2020, trauma accounts for nearly 40 Mn homicide and suicide deaths each year in the US occurred due to trauma. Trauma is the fourth-leading cause of death across all age groups across the globe.
Diagnostics imaging is recommended in trauma cases to detect damage to internal organs as well as severity of the damage. Increasing trauma cases globally is expected to boost growth of the contrast media injectors market.
Furthermore, in the approaching years, the expanding IT-enabled solutions in U.S for contrast media injectors will present additional potential development prospects for this market.
Why is Germany Considered a Lucrative Contrast media injectors Market?
Germany is estimated to account for 25.8% of the Western Europe contrast media injectors market in 2022, as a result of a well-established healthcare infrastructure.
Furthermore, market expansion is fueled by factors such as a rising demand for minimally invasive treatments and an increase in the incidence of chronic illnesses as a consequence of changing lifestyles.
Additionally, increasing prevalence of cancer among the geriatric population globally is expected to drive demand for contrast media injectors market.
According to reported data in 2020, by National Cancer Institute from their research, around 40% lives could be saved each year, by early diagnosis of cancer.
What are the Factors Fueling the Demand for Contrast media injectors in China?
The contrast media injectors market in China is estimated to be worth 53.1% market share in 2022 in the APEJ market owing to increased R&D investments, favorable demographic scenario.
In emerging country like China, the growing demand for quality healthcare facilities and high patient population with chronic diseases are the major factors expected to provide enormous opportunities for the manufacturers to expand their business in this region.
According to the latest reported data by world health organization, in 2020, non-communicable diseases account for an estimated 80% of total deaths and 70% of disability-adjusted life years lost in China. This is the area where diagnosis play an important role which is expected to lead the market growth in China.
How will the Contrast media injectors Market Expand across India?
Contrast media injectors in India is expected to have nearly 15.0% market share in the global market in 2022. The expansion of this sector is being driven by increased investment in the Indian radiology industry, increased emphasis of market participants, and increased government assistance to boost healthcare service delivery.
India is anticipated to grow at an impressive rate as patients are searching for low cost diagnosis with outpatient imaging. Demand for outpatient imaging is continuously increasing because the diagnostic centers offer more relaxed, personalized service and liberties which is more accepted by patient. CT and MRI growth have been exceptional, increasing at a rate of about 200% over the past 10 years.
Outpatient facilities are usually far less expensive than hospitals, as they offer discounts given by diagnostic centers which increases the demand and give opportunities for players to increase their production.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Category-wise Insights
Demand for CT Injectors continue gaining Traction
By Product, CT Injectors are anticipated to hold the maximum share of 43.0% in 2022 owing to their ability to aid in 3D visual reconstruction.
CT injectors are used to inject iodine-based contrast media for computed tomography procedure. Adoption of CT injectors for insertion of contrast media for various procedures such as X-ray and ultrasound is increasing.
CT injectors are used to enhance image quality while also increasing patient safety. These devices regulate contrast dose, keep track of how much is used, and accelerate injections to keep up with rapid CT scanners and alert users to possible dangers such as air embolisms or extravasations.
Why Hospital projected maximum growth in the Contrast media injectors Market?
By End User, Hospital pharmacies segment is anticipated to hold the maximum share of 49.4% in 2022. Hospitals have access to modern medical technology and its infrastructure is capable of delivering high-quality care for any disease condition. Hospitals are expected to account for a significant portion of the market, as the majority of people in both emerging and established countries prefer to visit hospitals for any health-related issue.
Additionally, the expanding number of hospitals and increased accessibility in emerging countries are expected to provide profitable prospects for the hospital segment to grow throughout the forecast period.
Furthermore, as the number of cancer, neurological, and cardiovascular patients admitted to hospitals rises, the industry will experience significant growth. The vast range of applications in radiology, interventional radiology, and interventional cardiology, hospitals are the principal users of high pressure contrast media injectors.
Competitive Landscape
Companies operating in the contrast media injectors market are competitive by nature, with a presence of few players. These players are involved in a number of strategic alliances.
The contrast media injector’s market players are trying out every possible mode of organic/inorganic growth to sustain themselves in the market. The product launch and acquisition accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:
- In May 2021, Bayer AG announced a collaboration with ArcherDX, Inc., which will focus on the global development and commercialization of therapy-accompanying diagnostic tests – also known as companion diagnostics (CDx) – for Vitrakvi™ (larotrectinib), based on next-generation sequencing.
- In May 2019, the ulrich’s CT contrast agent injector, CT motion, was made available in the world's most important medical technology market, the U.S.
Scope of the Report
|
Attribute |
Details |
|
Forecast Period |
2014-2021 |
|
Historical Data Available for |
2022-2030 |
|
Market Analysis |
USD Billion for Value and Units for Volume |
|
Key Countries Covered |
US, Canada, Brazil, Mexico, Germany, U.K., France, Italy, Spain, Poland, Russia, Greater China , Japan, India, Australia, New Zealand, GCC Countries, South Africa |
|
Key Segments Covered |
Product, End User and Region |
|
Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Contrast Media Injectors Market by Category
By Product:
- CT Injectors
- MRI Injectors
- Cardio Injectors
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Diagnostics Centers
By Region:
- North America
- Latin America
- Eastern Europe
- Western Europe
- APEJ
- Japan
- Middle East and Africa (MEA)
Frequently Asked Questions
The global contrast media injectors market is worth US$ 1.4 Bn in 2021 and is set to expand 1.6X over the forecasted years owing to the rising number of cardiac disorders and rising prevalence of cardiovascular disease cases.
The sales of contrast media injectors in the market have grown at a CAGR of nearly 5.4% between 2014 and 2021. The need for contrast media injectors is growing because of increasing physicians preference about the benefits related with contrast media injectable diagnosis.
The contrast media injectors market is expected to reach US$ 2.4 Bn by the end of 2030 with sales revenue expected to register CAGR of 6.2% over the forecast period.
North America currently holds the largest market share in the contrast media injectors. U.S. being the leading contributor with a market value over US$ 470.3 Mn in 2022.
At what percentage Contrast media injectors market is expected to register growth in Western Europe?
Demand of contrast media injectors market is expected to register growth in Western Europe at rate of 6.0% CAGR during the forecast period.
The contrast media injectors in China is likely to observe growth with an impressive market share of 53.1% in 2022 in APEJ market.
Rising adoption of technological advanced CT scan, growth of diagnostic imaging centers, and collaboration as the key strategy to expand the business are driving the sales of contrast media injectors market across the globe.
U.S., Japan, Germany, Greater China, and U.K. are the top 5 countries that are driving the demand for contrast media injectors market.
Leading companies of contrast media injectors are Bayer AG, Nemoto Kyorindo Co. Ltd., Mallinckrodt, Bracco Imaging, Ulrich GmBh, Guerbet SA, Medtron AG,
Table of Content
1. Assumptions & Acronyms Used
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.1.1. Market Taxonomy & Market Definition
4.2. Contrast Media Injectors Market Product Overview
4.3. Contrast Media Injectors Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.3.4. Trends
5. Global Contrast Media Injectors Market Forecast, 2014-2030
5.1. Introduction
5.1.1. Y-o-Y Growth Projection
5.1.2. Absolute $ Opportunity
5.2. Parent Market Overview
5.2.1. Introduction
5.2.1.1. Y-o-Y Growth Projection
5.2.1.2. Absolute $ Opportunity
5.3. Contrast Media Injectors Market Trends
5.4. Regional Average Pricing Analysis (2021)
5.5. Global Contrast Media Injectors Market Snapshot (2022)
6. Global Contrast Media Injectors Market Analysis, By Product
6.1. Introduction
6.1.1. Y-o-Y Growth Comparison, By Product
6.1.2. BPS Analysis, By Product
6.2. Market Value and Volume Forecast, By Product
6.2.1. CT Injectors
6.2.1.1. Absolute $ Opportunity
6.2.1.2. Market Value Forecast
6.2.2. MRI Injectors
6.2.2.1. Absolute $ Opportunity
6.2.2.2. Market Value Forecast
6.2.3. Cardiology Injectors
6.2.3.1. Absolute $ Opportunity
6.2.3.2. Market Value Forecast
6.3. Global Contrast Media Injectors Market Attractiveness Analysis, by Product Segment
7. Global Contrast Media Injectors Market Analysis, By End User
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison, By End User
7.1.2. BPS Analysis, By End User
7.2. Market Value and Volume Forecast, By End User
7.2.1. Hospitals
7.2.1.1. Absolute $ Opportunity
7.2.1.2. Market Value Forecast
7.2.2. Ambulatory Surgical Centres
7.2.2.1. Absolute $ Opportunity
7.2.2.2. Market Value Forecast
7.2.3. Diagnostics Centres
7.2.3.1. Absolute $ Opportunity
7.2.3.2. Market Value Forecast
7.3. Global Contrast Media Injectors Market Attractiveness Analysis, by End User Segment
8. Global Contrast Media Injectors Market Analysis, By Region
8.1. Introduction
8.1.1. Y-o-Y Growth Comparison, By Region
8.1.2. BPS Analysis, By Region
8.2. Market Value and Volume Forecast, By Region
8.2.1. North America
8.2.2. Latin America
8.2.3. Western Europe
8.2.4. Eastern Europe
8.2.5. APEJ
8.2.6. Japan
8.2.7. MEA
8.3. Global Contrast Media Injectors Market Attractiveness Analysis, by Region
9. North America Contrast Media Injectors Market Analysis
9.1. Introduction
9.1.1. Y-o-Y Growth Comparison
9.1.1.1. By Country
9.1.1.2. By Product
9.1.1.3. By End User
9.1.2. BPS Analysis
9.1.2.1. By Country
9.1.2.2. By Product
9.1.2.3. By End User
9.2. North America Market Forecast, By Country
9.2.1. U.S.
9.2.1.1. Absolute $ Opportunity
9.2.1.2. Market Value Forecast
9.2.2. Canada
9.2.2.1. Absolute $ Opportunity
9.2.2.2. Market Value Forecast
9.3. North America Market Forecast, By Product
9.3.1. CT Injectors
9.3.1.1. Absolute $ Opportunity
9.3.1.2. Market Value Forecast
9.3.2. MRI Injectors
9.3.2.1. Absolute $ Opportunity
9.3.2.2. Market Value Forecast
9.3.3. Cardiology Injectors
9.3.3.1. Absolute $ Opportunity
9.3.3.2. Market Value Forecast
9.4. North America Market Forecast, By End User
9.4.1. Hospitals
9.4.1.1. Absolute $ Opportunity
9.4.1.2. Market Value Forecast
9.4.2. Ambulatory Surgical Centres
9.4.2.1. Absolute $ Opportunity
9.4.2.2. Market Value Forecast
9.4.3. Diagnostics Centres
9.4.3.1. Absolute $ Opportunity
9.4.3.2. Market Value Forecast
9.5. North America Market Trends and Impact Analysis of Drivers & Restraints
10. Latin America Contrast Media Injectors Market Analysis
10.1. Introduction
10.1.1. Y-o-Y Growth Comparison
10.1.1.1. By Country
10.1.1.2. By Product
10.1.1.3. By End User
10.1.2. BPS Analysis
10.1.2.1. By Country
10.1.2.2. By Product
10.1.2.3. By End User
10.2. Latin America Market Forecast, By Country
10.2.1. Mexico
10.2.1.1. Absolute $ Opportunity
10.2.1.2. Market Value Forecast
10.2.2. Brazil
10.2.2.1. Absolute $ Opportunity
10.2.2.2. Market Value Forecast
10.2.3. Rest of Latin America
10.2.3.1. Absolute $ Opportunity
10.2.3.2. Market Value Forecast
10.3. Latin America Market Forecast, By Product
10.3.1. CT Injectors
10.3.1.1. Absolute $ Opportunity
10.3.1.2. Market Value Forecast
10.3.2. MRI Injectors
10.3.2.1. Absolute $ Opportunity
10.3.2.2. Market Value Forecast
10.3.3. Cardiology Injectors
10.3.3.1. Absolute $ Opportunity
10.3.3.2. Market Value Forecast
10.4. Latin America Market Forecast, By End User
10.4.1. Hospitals
10.4.1.1. Absolute $ Opportunity
10.4.1.2. Market Value Forecast
10.4.2. Ambulatory Surgical Centres
10.4.2.1. Absolute $ Opportunity
10.4.2.2. Market Value Forecast
10.4.3. Diagnostics Centres
10.4.3.1. Absolute $ Opportunity
10.4.3.2. Market Value Forecast
10.5. Latin America Market Trends and Impact Analysis of Drivers & Restraints
11. Western Europe Contrast Media Injectors Market Analysis
11.1. Introduction
11.1.1. Y-o-Y Growth Comparison
11.1.1.1. By Country
11.1.1.2. By Product
11.1.1.3. By End User
11.1.2. BPS Analysis
11.1.2.1. By Country
11.1.2.2. By Product
11.1.2.3. By End User
11.2. Western Europe Market Forecast, By Country
11.2.1. Germany
11.2.1.1. Absolute $ Opportunity
11.2.1.2. Market Value Forecast
11.2.2. France
11.2.2.1. Absolute $ Opportunity
11.2.2.2. Market Value Forecast
11.2.3. U.K.
11.2.3.1. Absolute $ Opportunity
11.2.3.2. Market Value Forecast
11.2.4. Spain
11.2.4.1. Absolute $ Opportunity
11.2.4.2. Market Value Forecast
11.2.5. Italy
11.2.5.1. Absolute $ Opportunity
11.2.5.2. Market Value Forecast
11.2.6. Rest of Western Europe
11.2.6.1. Absolute $ Opportunity
11.2.6.2. Market Value Forecast
11.3. Western Europe Market Forecast, By Product
11.3.1. CT Injectors
11.3.1.1. Absolute $ Opportunity
11.3.1.2. Market Value Forecast
11.3.2. MRI Injectors
11.3.2.1. Absolute $ Opportunity
11.3.2.2. Market Value Forecast
11.3.3. Cardiology Injectors
11.3.3.1. Absolute $ Opportunity
11.3.3.2. Market Value Forecast
11.4. Western Europe Market Forecast, By End User
11.4.1. Hospitals
11.4.1.1. Absolute $ Opportunity
11.4.1.2. Market Value Forecast
11.4.2. Ambulatory Surgical Centres
11.4.2.1. Absolute $ Opportunity
11.4.2.2. Market Value Forecast
11.4.3. Diagnostics Centres
11.4.3.1. Absolute $ Opportunity
11.4.3.2. Market Value Forecast
11.5. Western Europe Market Trends and Impact Analysis of Drivers & Restraints
12. Eastern Europe Contrast Media Injectors Market Analysis
12.1. Introduction
12.1.1. Y-o-Y Growth Comparison
12.1.1.1. By Country
12.1.1.2. By Product
12.1.1.3. By End User
12.1.2. BPS Analysis
12.1.2.1. By Country
12.1.2.2. By Product
12.1.2.3. By End User
12.2. Eastern Europe Market Forecast, By Country
12.2.1. Russia
12.2.1.1. Absolute $ Opportunity
12.2.1.2. Market Value Forecast
12.2.2. Poland
12.2.2.1. Absolute $ Opportunity
12.2.2.2. Market Value Forecast
12.2.3. Rest of Eastern Europe
12.2.3.1. Absolute $ Opportunity
12.2.3.2. Market Value Forecast
12.3. Eastern Europe Market Forecast, By Product
12.3.1. CT Injectors
12.3.1.1. Absolute $ Opportunity
12.3.1.2. Market Value Forecast
12.3.2. MRI Injectors
12.3.2.1. Absolute $ Opportunity
12.3.2.2. Market Value Forecast
12.3.3. Cardiology Injectors
12.3.3.1. Absolute $ Opportunity
12.3.3.2. Market Value Forecast
12.4. Eastern Europe Market Forecast, By End User
12.4.1. Hospitals
12.4.1.1. Absolute $ Opportunity
12.4.1.2. Market Value Forecast
12.4.2. Ambulatory Surgical Centres
12.4.2.1. Absolute $ Opportunity
12.4.2.2. Market Value Forecast
12.4.3. Diagnostics Centres
12.4.3.1. Absolute $ Opportunity
12.4.3.2. Market Value Forecast
12.5. Eastern Europe Market Trends and Impact Analysis of Drivers & Restraints
13. APEJ Contrast Media Injectors Market
13.1. Introduction
13.1.1. Y-o-Y Growth Comparison
13.1.1.1. By Country
13.1.1.2. By Product
13.1.1.3. By End User
13.1.2. BPS Analysis
13.1.2.1. By Country
13.1.2.2. By Product
13.1.2.3. By End User
13.2. APEJ Market Forecast, By Country
13.2.1. Greater China
13.2.1.1. Absolute $ Opportunity
13.2.1.2. Market Value Forecast
13.2.2. India
13.2.2.1. Absolute $ Opportunity
13.2.2.2. Market Value Forecast
13.2.3. Australia and New Zealand
13.2.3.1. Absolute $ Opportunity
13.2.3.2. Market Value Forecast
13.2.4. Rest of APEJ
13.2.4.1. Absolute $ Opportunity
13.2.4.2. Market Value Forecast
13.3. APEJ Market Forecast, By Product
13.3.1. CT Injectors
13.3.1.1. Absolute $ Opportunity
13.3.1.2. Market Value Forecast
13.3.2. MRI Injectors
13.3.2.1. Absolute $ Opportunity
13.3.2.2. Market Value Forecast
13.3.3. Cardiology Injectors
13.3.3.1. Absolute $ Opportunity
13.3.3.2. Market Value Forecast
13.4. APEJ Market Forecast, By End User
13.4.1. Hospitals
13.4.1.1. Absolute $ Opportunity
13.4.1.2. Market Value Forecast
13.4.2. Ambulatory Surgical Centres
13.4.2.1. Absolute $ Opportunity
13.4.2.2. Market Value Forecast
13.4.3. Diagnostics Centres
13.4.3.1. Absolute $ Opportunity
13.4.3.2. Market Value Forecast
13.5. APEJ Market Trends and Impact Analysis of Drivers & Restraints
14. Japan Contrast Media Injectors Market
14.1. Introduction
14.1.1. Y-o-Y Growth Comparison
14.1.1.1. By Product
14.1.1.2. By End User
14.1.2. BPS Analysis
14.1.2.1. By Product
14.1.2.2. By End User
14.2. Japan Market Forecast, By Product
14.2.1. CT Injectors
14.2.1.1. Absolute $ Opportunity
14.2.1.2. Market Value Forecast
14.2.2. MRI Injectors
14.2.2.1. Absolute $ Opportunity
14.2.2.2. Market Value Forecast
14.2.3. Cardiology Injectors
14.2.3.1. Absolute $ Opportunity
14.2.3.2. Market Value Forecast
14.3. Japan Market Forecast, By End User
14.3.1. Hospitals
14.3.1.1. Absolute $ Opportunity
14.3.1.2. Market Value Forecast
14.3.2. Ambulatory Surgical Centres
14.3.2.1. Absolute $ Opportunity
14.3.2.2. Market Value Forecast
14.3.3. Diagnostics Centres
14.3.3.1. Absolute $ Opportunity
14.3.3.2. Market Value Forecast
14.4. Japan Market Trends and Impact Analysis of Drivers & Restraints
15. MEA Contrast Media Injectors Market
15.1. Introduction
15.1.1. Y-o-Y Growth Comparison
15.1.1.1. By Country
15.1.1.2. By Product
15.1.1.3. By End User
15.1.2. BPS Analysis
15.1.2.1. By Country
15.1.2.2. By Product
15.1.2.3. By End User
15.2. MEA Market Forecast, By Country
15.2.1. GCC
15.2.1.1. Absolute $ Opportunity
15.2.1.2. Market Value Forecast
15.2.2. South Africa
15.2.2.1. Absolute $ Opportunity
15.2.2.2. Market Value Forecast
15.2.3. Rest of MEA
15.2.3.1. Absolute $ Opportunity
15.2.3.2. Market Value Forecast
15.3. MEA Market Forecast, By Product
15.3.1. CT Injectors
15.3.1.1. Absolute $ Opportunity
15.3.1.2. Market Value Forecast
15.3.2. MRI Injectors
15.3.2.1. Absolute $ Opportunity
15.3.2.2. Market Value Forecast
15.3.3. Cardiology Injectors
15.3.3.1. Absolute $ Opportunity
15.3.3.2. Market Value Forecast
15.4. MEA Market Forecast, By End User
15.4.1. Hospitals
15.4.1.1. Absolute $ Opportunity
15.4.1.2. Market Value Forecast
15.4.2. Ambulatory Surgical Centres
15.4.2.1. Absolute $ Opportunity
15.4.2.2. Market Value Forecast
15.4.3. Diagnostics Centres
15.4.3.1. Absolute $ Opportunity
15.4.3.2. Market Value Forecast
15.5. MEA Market Trends and Impact Analysis of Drivers & Restraints
16. Competitive Landscape
16.1. Competition Dashboard
16.2. Company Share Analysis
16.3. Mallinckrodt
16.4. Guerbet SA
16.5. Bayer AG
16.6. Bracco Imaging S.p.A.
16.7. Ulrich GmbH & Co. KG
16.8. Medtron
16.9. Nemoto Kyorindo Co. Ltd
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Contrast Media Injectors Market Value Forecast, by Product Segment, 2014–2030 (US$ Mn)
Table 2: Global Contrast Media Injectors Market Volume Forecast, by Product Segment, 2014–2030 (Units)
Table 3: Global Contrast Media Injectors Market Value Forecast, by End User, 2014–2030 (US$ Mn)
Table 4: Global Contrast Media Injectors Market Volume Forecast, by End User, 2014–2030 (Units)
Table 5: Global Contrast Media Injectors Market Value Forecast By Region, 2014–2030 (US$ Mn)
Table 6: Global Contrast Media Injectors Market Volume Forecast By Region, 2014–2030 (Units)
Table 7: North America Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)
Table 8: North America Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)
Table 9: North America Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)
Table 10: Latin America Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)
Table 11: Latin America Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)
Table 12: Latin America Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)
Table 13: Western Europe Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)
Table 14: Western Europe Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)
Table 15: Western Europe Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)
Table 16: Eastern Europe Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)
Table 17: Eastern Europe Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)
Table 18: Eastern Europe Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)
Table 19: APEJ Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)
Table 20: APEJ Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)
Table 21: APEJ Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)
Table 22: Japan Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)
Table 23: Japan Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)
Table 24: MEA Contrast Media Injectors Market Value Forecast, by Country, 2014–2030 (US$ Mn)
Table 25: MEA Contrast Media Injectors Market Value Forecast, by Product, 2014–2030 (US$ Mn)
Table 26: MEA Contrast Media Injectors Market Volume Forecast, by Product, 2014–2030 (Units)
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Contrast Media Injectors Market,
Figure 2: Global Diagnostics Imaging Devices Market Value Forecast, 2014–2030 (US$ Mn)
Figure 3: Global CT Contrast Media Injectors Price Difference (US$), by Region, 2021
Figure 4: Global CT Contrast Media Injectors Price Difference (US$), by Region, 2030
Figure 5: Global MRI Contrast Media Injectors Price Difference (US$), by Region, 2021
Figure 6: Global MRI Contrast Media Injectors Price Difference (US$), by Region, 2030
Figure 7: Global Cardiology Contrast Media Injectors Price Difference (US$), by Region, 2021
Figure 8: Global Cardiology Contrast Media Injectors Price Difference (US$), by Region, 2030
Figure 9: Global Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030
Figure 10: Global Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030
Figure 11: Global Contrast Media Injectors Market Value (US$ Mn) &
Figure 12: Global Contrast Media Injectors Market Absolute $ Opportunity
Figure 13: Global Contrast Media Injectors Market Value (US$ Mn) &
Figure 14: Global Contrast Media Injectors Market Absolute $ Opportunity
Figure 15: Global Contrast Media Injectors Market Value (US$ Mn) &
Figure 16: Global Contrast Media Injectors Market Absolute $ Opportunity
Figure 17: Global Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030
Figure 18: Global Contrast Media Injectors Market Value Share, by End User, 2014–2030
Figure 19: Global Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030
Figure 20: Global Contrast Media Injectors Market Value (US$ Mn) &
Figure 21: Global Contrast Media Injectors Market Absolute $ Opportunity
Figure 22: Global Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030
Figure 23: Global Contrast Media Injectors Market Absolute $ Opportunity
Figure 24: Global Contrast Media Injectors Market Value (US$ Mn) &
Figure 25: Global Contrast Media Injectors Market Absolute $ Opportunity
Figure 26: Global Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030
Figure 27: Global Contrast Media Injectors Market Value Share, by Region, 2014–2030
Figure 28: Global Contrast Media Injectors Market Y-o-Y Growth Rate, by Region, 2014–2030
Figure 29: Global Contrast Media Injectors Market Attractiveness Analysis, by Region, 2014–2030
Figure 30: North America Contrast Media Injectors Market Y-o-Y Growth Rate, by Country, 2014–2030
Figure 31: North America Contrast Media Injectors Market Value Share, by Country, 2014–2030
Figure 32: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by the U.S., 2014–2030
Figure 33: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by the U.S., 2014–2030
Figure 34: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Canada, 2014–2030
Figure 35: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Canada, 2014–2030
Figure 36: North America Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030
Figure 37: North America Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030
Figure 38: North America Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030
Figure 39: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030
Figure 40: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030
Figure 41: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030
Figure 42: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030
Figure 43: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030
Figure 44: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030
Figure 45: North America Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030
Figure 46: North America Contrast Media Injectors Market Value Share, by End User, 2014–2030
Figure 47: North America Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030
Figure 48: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030
Figure 49: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030
Figure 50: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030
Figure 51: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030
Figure 52: North America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030
Figure 53: North America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030
Figure 54: North America Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030
Figure 55: Latin America Contrast Media Injectors Market Y-o-Y Growth Rate, by Country, 2014–2030
Figure 56: Latin America Contrast Media Injectors Market Value Share, by Country, 2014–2030
Figure 57: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Mexico, 2014–2030
Figure 58: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Mexico, 2014–2030
Figure 59: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Brazil, 2014–2030
Figure 60: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Brazil, 2014–2030
Figure 61: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Rest of Latin America, 2014–2030
Figure 62: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Rest of Latin America, 2014–2030
Figure 63: Latin America Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030
Figure 64: Latin America Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030
Figure 65: Latin America Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030
Figure 66: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030
Figure 67: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030
Figure 68: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030
Figure 69: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030
Figure 70: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030
Figure 71: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030
Figure 72: Latin America Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030
Figure 73: Latin America Contrast Media Injectors Market Value Share, by End User, 2014–2030
Figure 74: Latin America Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030
Figure 75: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030
Figure 76: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030
Figure 77: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030
Figure 78: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030
Figure 79: Latin America Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030
Figure 80: Latin America Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030
Figure 81: Latin America Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030
Figure 82: Western Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by Country, 2014–2030
Figure 83: Western Europe Contrast Media Injectors Market Value Share, by Country, 2014–2030
Figure 84: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Germany, 2014–2030
Figure 85: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Germany, 2014–2030
Figure 86: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by France, 2014–2030
Figure 87: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by France, 2014–2030
Figure 88: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by The U.K., 2014–2030
Figure 89: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by The U.K., 2014–2030
Figure 90: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Spain, 2014–2030
Figure 91: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Spain, 2014–2030
Figure 92: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Italy, 2014–2030
Figure 93: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Italy, 2014–2030
Figure 94: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Rest of Western Europe, 2014–2030
Figure 95: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Rest of Western Europe, 2014–2030
Figure 96: Western Europe Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030
Figure 97: Western Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030
Figure 98: Western Europe Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030
Figure 99: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030
Figure 100: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030
Figure 101: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030
Figure 102: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030
Figure 103: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030
Figure 104: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030
Figure 105: Western Europe Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030
Figure 106: Western Europe Contrast Media Injectors Market Value Share, by End User, 2014–2030
Figure 107: Western Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030
Figure 108: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030
Figure 109: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030
Figure 110: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030
Figure 111: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030
Figure 112: Western Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030
Figure 113: Western Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030
Figure 114: Western Europe Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030
Figure 115: Eastern Europe Contrast Media Injectors Market Value Share, by Country, 2014–2030
Figure 116: Eastern Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by Country, 2014–2030
Figure 117: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Poland, 2014–2030
Figure 118: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Poland, 2014–2030
Figure 119: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Russia, 2014–2030
Figure 120: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Russia, 2014–2030
Figure 121: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Rest of Eastern Europe, 2014–2030
Figure 122: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Rest of Eastern Europe, 2014–2030
Figure 123: Eastern Europe Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030
Figure 124: Eastern Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030
Figure 125: Eastern Europe Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030
Figure 126: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030
Figure 127: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030
Figure 128: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030
Figure 129: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030
Figure 130: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030
Figure 131: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030
Figure 132: Eastern Europe Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030
Figure 133: Eastern Europe Contrast Media Injectors Market Value Share, by End User, 2014–2030
Figure 134: Eastern Europe Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030
Figure 135: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030
Figure 136: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030
Figure 137: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030
Figure 138: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030
Figure 139: Eastern Europe Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030
Figure 140: Eastern Europe Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030
Figure 141: Eastern Europe Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030
Figure 142: APEJ Contrast Media Injectors Market Value Share, by Country, 2014–2030
Figure 143: APEJ Contrast Media Injectors Market Y-o-Y Growth Rate, by Country, 2014–2030
Figure 144: APEJ Contrast Media Injectors Market Value (US$ Mn) &
Figure 145: APEJ Contrast Media Injectors Market Absolute $ Opportunity
Figure 146: APEJ Contrast Media Injectors Market Value (US$ Mn) &
Figure 147: APEJ Contrast Media Injectors Market Absolute $ Opportunity
Figure 148: APEJ Contrast Media Injectors Market Value (US$ Mn) &
Figure 149: APEJ Contrast Media Injectors Market Absolute $ Opportunity
Figure 150: APEJ Contrast Media Injectors Market Value (US$ Mn) &
Figure 151: APEJ Contrast Media Injectors Market Absolute $ Opportunity
Figure 152: APEJ Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030
Figure 153: APEJ Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030
Figure 154: APEJ Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030
Figure 155: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030
Figure 156: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030
Figure 157: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030
Figure 158: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030
Figure 159: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030
Figure 160: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030
Figure 161: APEJ Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030
Figure 162: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030
Figure 163: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030
Figure 164: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030
Figure 165: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030
Figure 166: APEJ Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030
Figure 167: APEJ Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030
Figure 168: APEJ Contrast Media Injectors Market Value Share, by End User, 2014–2030
Figure 169: APEJ Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030
Figure 170: APEJ Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030
Figure 171: Japan Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030
Figure 172: Japan Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030
Figure 173: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030
Figure 174: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030
Figure 175: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030
Figure 176: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030
Figure 177: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030
Figure 178: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030
Figure 179: Japan Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030
Figure 180: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030
Figure 181: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030
Figure 182: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by ASCs End User Segment, 2014–2030
Figure 183: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by ASCs End User Segment, 2014–2030
Figure 184: Japan Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030
Figure 185: Japan Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030
Figure 186: Japan Contrast Media Injectors Market Value Share, by End User, 2014–2030
Figure 187: Japan Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030
Figure 188: Japan Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030
Figure 189: MEA Contrast Media Injectors Market Value Share, by Country, 2014–2030
Figure 190: MEA Contrast Media Injectors Market Y-o-Y Growth Rate, by Country, 2014–2030
Figure 191: MEA Contrast Media Injectors Market Value (US$ Mn) &
Figure 192: MEA Contrast Media Injectors Market Absolute $ Opportunity
Figure 193: MEA Contrast Media Injectors Market Value (US$ Mn) &
Figure 194: MEA Contrast Media Injectors Market Absolute $ Opportunity
Figure 195: MEA Contrast Media Injectors Market Value (US$ Mn) &
Figure 196: MEA Contrast Media Injectors Market Absolute $ Opportunity
Figure 197: MEA Contrast Media Injectors Market Attractiveness Analysis, by Country, 2014–2030
Figure 198: MEA Contrast Media Injectors Market Y-o-Y Growth Rate, by Product Segment, 2014–2030
Figure 199: MEA Contrast Media Injectors Market Value Share, by Product Segment, 2014–2030
Figure 200: MEA Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by CT Injectors Product Segment, 2014–2030
Figure 201: MEA Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by CT Injectors Product Segment, 2014–2030
Figure 202: MEA Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by MRI Injectors Product Segment, 2014–2030
Figure 203: MEA Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by MRI Injectors Product Segment, 2014–2030
Figure 204: MEA Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Cardiology Injectors Product Segment, 2014–2030
Figure 205: MEA Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Cardiology Injectors Product Segment, 2014–2030
Figure 206: MEA Contrast Media Injectors Market Attractiveness Analysis, by Product Segment, 2014–2030
Figure 207: MEA Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Hospitals End User Segment, 2014–2030
Figure 208: MEA Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Hospitals End User Segment, 2014–2030
Figure 209: MEA Contrast Media Injectors Market Value (US$ Mn) & Y-o-Y Growth, by Diagnostic Centres End User Segment, 2014–2030
Figure 210: MEA Contrast Media Injectors Market Absolute $ Opportunity (US$ Mn), by Diagnostic Centres End User Segment, 2014–2030
Figure 211: MEA Contrast Media Injectors Market Value Share, by End User, 2014–2030
Figure 212: MEA Contrast Media Injectors Market Y-o-Y Growth Rate, by End User, 2014–2030
Figure 213: MEA Contrast Media Injectors Market Attractiveness Analysis, by End User, 2014–2030
Figure 214: Global Contrast Media Injectors Company Market Share Analysis, 2021
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
